Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...
AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and ...
Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can ...
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...
A team of researchers has reported a significant advance in Alzheimer’s treatment. Their candidate drug, RI-AG03, attacks the ...
In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...
For the first time, scientists have developed a drug that works on both major aggregation-promoting "hotspots" of the Tau protein - addressing a critical gap in current treatments.
Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...
An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback